Patents by Inventor Olivier Siri

Olivier Siri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHENAZINE DERIVATIVE AND USE THEREOF FOR THE TREATMENT OF CANCER
    Publication number: 20220315539
    Abstract: A compound of formula (I), wherein R1, R2, R3 and R4 are selected from a saturated or unsaturated, branched or unbranched, cyclic or non-cyclic alkyl, or an amide, or a functional group, or a salt or a solvate thereof, or a protonated form thereof, and to the use thereof for the treatment of cancer.
    Type: Application
    Filed: September 2, 2020
    Publication date: October 6, 2022
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'AIX-MARSEILLE
    Inventors: Olivier SIRI, Zhongrui CHEN
  • Analogues of porphyrins, their method of preparation and use thereof
    Patent number: 9156800
    Abstract: The present invention relates to compound of formula (I), their method of preparation and use thereof in particular in the fields of optoelectronic, photonic, photovoltaics and biology.
    Type: Grant
    Filed: September 2, 2013
    Date of Patent: October 13, 2015
    Assignees: UNIVERSITÉ D'AIX-MARSEILLE, UNIVERSITÉ DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Olivier Siri, Zhongrui Chen, Denis Jacquemin
  • ANALOGUES OF PORPHYRINS, THEIR METHOD OF PREPARATION AND USE THEREOF
    Publication number: 20150210653
    Abstract: The present invention relates to compound of formula (I), their method of preparation and use thereof in particular in the fields of optoelectronic, photonic, photovoltaics and biology.
    Type: Application
    Filed: September 2, 2013
    Publication date: July 30, 2015
    Applicant: Université D'Aix-Marseille
    Inventors: Olivier Siri, Zhongrui Chen, Denis Jacquemin
  • Nitric oxide carriers based on polyazamacrocycle complexes
    Patent number: 6310202
    Abstract: Novel compounds capable of carrying and releasing nitrogen oxide (NO) in a biological medium, their use for implementing a therapeutic treatment method or a diagnostic method applied to a human or animal body, and for making medicines useful for treating or preventing disorders affecting the human or animal cardiovascular, nervous, immune, renal or pulmonary system, specifically, an organometallic complex of nitrogen oxide, wherein the cationic part is of the formula (I) in which x=0 or 1; x′=2 or 3; y=0, 2 or 3; z=0 or 1; with the condition that, if y=0 (or z=0) then z=0 (or y=0; respectively); R is a group chosen from the group formed by: a hydrogen atom, —(CH2)2COOH and R1, R2, R3 and R4 are groups chosen from the group formed by: a hydrogen atom and alkyl groups comprising from 1 to 4 carbon atoms; and M2+ is a divalent cation Fe++ or Co++.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: October 30, 2001
    Assignee: L'Air Liquide, Societe Anonyme pour l'Etude Et l'Exploitation des Procedes Georges Claude
    Inventors: Alain Tabard, Olivier Siri, Panayotis Cocolios, Roger Guilard